New Delhi, Feb. 8 -- justify;">One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often leads to treatment failure. When we say the body "resists" cancer treatment, it typically refers to the cancer cells' ability to evade or withstand the effects of the treatment.

In an interview with HT Lifestyle, Dr Anjali Kulkarni, Vice President - RWE Strategy and Analytics and Oncologist at 4baseCare, expalined, "Drug resistance means the cancer cells do not respond to the treatment as expected. There may be partial response or in some cases there may be relapse of the disease despite the best treatment protocol. Sometimes drug resistance develops quickly, within a matter of weeks...